» Articles » PMID: 31379981

Red Blood Cell Distribution Width Predicts Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease

Overview
Journal Can Respir J
Publisher Wiley
Specialty Pulmonary Medicine
Date 2019 Aug 6
PMID 31379981
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study aims at investigating the predictive value of red blood cell distribution width (RDW) in pulmonary hypertension (PH) secondary to chronic obstructive pulmonary disease (COPD).

Methods: 213 eligible in-hospital COPD patients were reviewed between May 2016 and May 2018, including 39 cases with PH and 174 without PH. Clinical data including demographic characteristics, comorbidities, and results of ultrasound scans, imaging examinations, and laboratory tests were recorded.

Results: Increased RDW level was observed in COPD patients with PH compared with COPD patients without PH, with 15.10 ± 1.72% versus 13.70 ± 1.03%, respectively ( < 0.001). RDW shared positive relationships with brain natriuretic peptide (BNP) (=0.001,  = 0.513), pulmonary artery (PA) systolic pressure (=0.014,  = 0.390), and PA-to-ascending aorta (A) ratio (PA : A) (=0.001,  = 0.502). Multivariate analysis indicated that RDW, BNP, and PA : A > 1 were the independent risk factors of PH secondary to COPD ( < 0.05). The AUC of the RDW in patients with PH was 0.749 ± 0.054 ( < 0.001). The optimal cutoff value of RDW for predicting PH was 14.65, with a sensitivity and a specificity value of 69.2% and 82.8%, respectively.

Conclusion: RDW is significantly increased in COPD patients with PH and thus may be a useful biomarker for PH secondary to COPD.

Citing Articles

Analysis of clinical features and risk factors of pulmonary hypertension associated with interstitial lung disease.

Liao Y, Wu B Biomed Rep. 2025; 22(4):58.

PMID: 39991007 PMC: 11843187. DOI: 10.3892/br.2025.1936.


Development and validation of a mortality predictive model for ICU patients with primary pulmonary hypertension.

Zhang C, Hu Y, Meng Z, Lu C, Xie Y, Yu Q Sci Rep. 2024; 14(1):31497.

PMID: 39732999 PMC: 11682143. DOI: 10.1038/s41598-024-83139-3.


Investigating the Utility of Red Blood Cell Distribution Width as a Prognostic Indicator for Deterioration of Patients with Chronic Obstructive Pulmonary Disease Within One Year.

Liu Q, Wu K, Lin X, Xiang K, Wang J Int J Gen Med. 2024; 17:3869-3877.

PMID: 39263590 PMC: 11387594. DOI: 10.2147/IJGM.S469209.


Analysis of clinical characteristics of patients with pulmonary hypertension in Chaya County, Chamdo, Tibet.

Dong R, Shui X, Zhang J, Dun Z Cardiovasc Diagn Ther. 2024; 14(4):462-477.

PMID: 39263471 PMC: 11384449. DOI: 10.21037/cdt-23-486.


Predictive role of red blood cell distribution width and hemoglobin-to-red blood cell distribution width ratio for mortality in patients with COPD: evidence from NHANES 1999-2018.

Liu S, Zhang H, Zhu P, Chen S, Lan Z BMC Pulm Med. 2024; 24(1):413.

PMID: 39187816 PMC: 11348710. DOI: 10.1186/s12890-024-03229-w.


References
1.
Pristera N, Musarra R, Schilz R, Hoit B . The Role of Echocardiography in the Evaluation of Pulmonary Arterial Hypertension. Echocardiography. 2015; 33(1):105-16. DOI: 10.1111/echo.13113. View

2.
Hampole C, Mehrotra A, Thenappan T, Gomberg-Maitland M, Shah S . Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol. 2009; 104(6):868-72. DOI: 10.1016/j.amjcard.2009.05.016. View

3.
Liu S, Wang P, Shen P, Zhou J . Predictive Values of Red Blood Cell Distribution Width in Assessing Severity of Chronic Heart Failure. Med Sci Monit. 2016; 22:2119-25. PMC: 4920102. DOI: 10.12659/msm.898103. View

4.
Rhodes C, Wharton J, Howard L, Gibbs J, Wilkins M . Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 2011; 97(13):1054-60. DOI: 10.1136/hrt.2011.224857. View

5.
Seyhan E, Ozgul M, Tutar N, Omur I, Uysal A, Altin S . Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. COPD. 2013; 10(4):416-24. DOI: 10.3109/15412555.2012.758697. View